Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

Exclusive interview

INC Research expands into Middle East with MEK acquisition

10-Mar-2014 - In a sign of further consolidation, CRO INC Research has acquired CRO MEK Consulting and will absorb its more than 40 employees based in the Middle East and north Africa.

DSM's pharma biz reports slight growth before Patheon merger

26-Feb-2014 - DSM has reported modest growth in its pharma business as a shareholders advisory firm comes out in favour of the upcoming merger with Patheon.

Private equity firm buys Medpace for $915m, citing growth opportunities

24-Feb-2014 - CRO consolidation has left market opportunities for providers who serve mid-size pharma, UK-based private equity firm Cinven says as it acquires Medpace.

Icon: FY13 bolstered by M&A strategy, bolt-on acqusitions to continue

24-Feb-2014 - Icon says it intends to continue its M&A strategy focusing on capabilities, geographies and technologies as it reports a robust 2013.

Pharma consolidation a boon to CROs, but only the larger ones, report says

19-Feb-2014 - Mid-tier pharma mergers and a shift to more complex trials will benefit broad-based CROs, whilst smaller outsourcing partners will be forced to consolidate, an industry report by Citi Research predicts.

CRL to close MI research model unit, as preclinical biz blossoms

12-Feb-2014 - Charles River Laboratories says it will shutter a Research Models and Services (RMS) facility in Michigan as softened demand for the sector offset a strong year for its preclinical service...

CTI Trial, Clinical Consulting acquire Community Research

03-Feb-2014 - CROs CTI Trial and Clinical Consulting recently acquired Community Research, David Blume, managing director of Edgemont Capital, told us.

Catalent looks to go public with $100m IPO

30-Jan-2014 - Catalent has filed an initial public offering (IPO) with the SEC to raise $100m though this could reach upwards of $500m, according to one investment firm.

News in brief

GVK Bio to move into US with Aragen Purchase

30-Jan-2014 - Asia’s leading small-molecule CRO GVK BIO will acquire the capital stock of US-based CRO Aragen Bioscience. 

CRL looks to strategic alliances to drive growth across changing clientbase

20-Jan-2014 - Strategic relationships with both big pharma and mid-tier firms will drive future growth, says Charles River laboratories (CRL).

McKesson's strategy unclear after $8.3bn Celsio takeover falls through

14-Jan-2014 - Whether McKesson will relaunch its bid to acquire German logistics firm Celsio has been questioned by analysts after the proposed $8.3bn (€6.1bn) takeover bid fell through.

Merck Millipore sells its discovery and development service biz to Eurofins

09-Jan-2014 - Merck Millipore has sold its Discovery and Development Solutions (DDS) Business to Eurofins saying it was unable to fully support.

Patheon third largest CMO and top PDS provider, report says as DSM merger looms

08-Jan-2014 - Patheon is the world’s largest pharmaceutical development services (PDS) provider and third largest contract manufacturer, according to a report released yesterday.

Cyprotex buys CeeTox to expand preclinical services biz

02-Jan-2014 - Cyprotex has bought CeeTox in a bid to diversify its revenue base beyond its core pharmaceutical preclinical services business.

Chiltern consolidates ownership after Kester Capital sells stake

19-Dec-2013 - A private equity investor has sold its stake in CRO Chiltern leading to a restructured ownership the firm says will encourage expansion.

Algorithme teams with Montreal hospital to expand breadth of services

12-Dec-2013 - Algorithme Pharma has increased early stage patient access by teaming with a Montreal hospital, and says it provides a breadth of therapeutic areas not normally associated with mid-sized CROs.

Venn continues growth with $1.1m purchase of Northern Irish CRO

10-Dec-2013 - Venn Life Sciences has purchased Belfast, UK CRO Medevol in its second acquisition in as many months.

Patheon announces UK expansion and posts improved financials for fiscal 2013

03-Dec-2013 - Soon to merge CMO Patheon has increased solid dosage form production capacity at its site in the UK and posted an improved set of preliminary results for the financial year.

Dispatches from PCT

Parexel: Strategic partnerships are reshaping the CRO industry

02-Dec-2013 - Strategic partnerships are “the next phase” of sponsor-CRO relations, according to Parexel, and on top of saving pharma on oversight costs will reshape the industry. 

Dispatches from PCT

Not all good news: CROs must prepare for Private Equity exit, experts say

02-Dec-2013 - Private equity will be looking to exit the CRO industry and could pose a threat to recent strong growth, according to financial experts at PCT

Dispatches from PCT

Quintiles is the "arms, legs and brain" in Merck Serono's monogamous relationship

02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”

Venn acquires German CRO and says there's more to come

18-Nov-2013 - Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.

breaking news

PRA to buy CRI Lifetree

13-Nov-2013 - US CRO PRA International has announced plans to buy privately-owned early phase trial specialist CRI Lifetree.


'CROs on the move': inVentiv's new UK site; Novum in North Dakota

29-Oct-2013 - inVentiv Health has opened a new UK office in order to better target European customers, whilst Novum says its North Dakota facility will strengthen its offerings.

Aenova growing through consolidation with Haupt acquisition

28-Oct-2013 - CDMO Aenova has continued its strategy of consolidation with the acquisition of Haupt Pharma.